Current and emerging treatment options for myopic choroidal neovascularization
Leila El Matri, Ahmed Chebil, Fedra Kort Department B of Ophthalmology, Hedi Rais Institute of Ophthalmology, Faculty of Medicine of Tunis, University of El Manar, Tunis, Tunisia Abstract: Choroidal neovascularization (CNV) is the main cause of visual impairment in highly myopic patients younger t...
Main Authors: | El Matri L, Chebil A, Kort F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-04-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/current-and-emerging-treatment-options-for-myopic-choroidal-neovascula-peer-reviewed-article-OPTH |
Similar Items
-
Analysis on macular choroidal thickness of patients with myopic choroidal neovascularization
by: Yan Qiu, et al.
Published: (2015-05-01) -
Single intravitreal ranibizumab for myopic choroidal neovascularization
by: Shatriah I, et al.
Published: (2011-08-01) -
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
by: Jia-Kang Wang, et al.
Published: (2018-09-01) -
Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
by: Milani P, et al.
Published: (2016-09-01) -
Myopic choroidal neovascular membrane: A retrospective study
by: S Sindhu, et al.
Published: (2016-01-01)